Read More Pharma Industry News Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million,… bySrinathFebruary 16, 2022